BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$6.32B |
| 2 |
Microsoft
MSFT
|
+$5.03B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$3.87B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$3.27B |
| 5 |
Amazon
AMZN
|
+$2.75B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$2.54B |
| 2 |
COOP
Mr. Cooper
COOP
|
+$1.79B |
| 3 |
DuPont de Nemours
DD
|
+$1.69B |
| 4 |
SNDK
Sandisk
SNDK
|
+$1.29B |
| 5 |
Mastercard
MA
|
+$1.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.74% |
| 2 | Financials | 12.64% |
| 3 | Healthcare | 10.23% |
| 4 | Consumer Discretionary | 9.82% |
| 5 | Communication Services | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
Horizon Technology Finance
HRZN
$328M
| $1.86M | ﹤0.01% |
287,947
-12,627
| -4% | -$80.7K |
|
|
VELO
3927
Velo3D Inc
VELO
$408M
| $1.86M | ﹤0.01% |
+135,115
| New | +$929K |
|
3928
MacroGenics
MGNX
$249M
| $1.86M | ﹤0.01% |
1,152,649
-386,045
| -25% | -$607K |
|
|
LMRI
3929
Lumexa Imaging Holdings
LMRI
$1.12B
| $1.85M | ﹤0.01% |
+100,000
| New | +$1.81M |
|
3930
TriplePoint Venture Growth BDC
TPVG
$214M
| $1.85M | ﹤0.01% |
282,768
-30
| -0% | -$180 |
|
3931
TScan Therapeutics
TCRX
$50.8M
| $1.85M | ﹤0.01% |
1,848,695
-534,069
| -22% | -$773K |
|
|
SBC
3932
SBC Medical Group
SBC
$328M
| $1.84M | ﹤0.01% |
426,567
+154,791
| +57% | +$590K |
|
3933
Karyopharm Therapeutics
KPTI
$47.6M
| $1.82M | ﹤0.01% |
247,558
+15,607
| +7% | +$95.4K |
|
3934
Nexa Resources
NEXA
$1.91B
| $1.81M | ﹤0.01% |
204,992
+129,325
| +171% | +$842K |
|
3935
BRC Group Holdings
RILY
$292M
| $1.81M | ﹤0.01% |
387,807
+20,315
| +6% | +$101K |
|
3936
iShares MSCI Singapore ETF
EWS
$1.17B
| $1.81M | ﹤0.01% |
65,635
-828,497
| -93% | -$23.3M |
|
|
FGNX
3937
FG Nexus Inc
FGNX
$39.9M
| $1.8M | ﹤0.01% |
130,809
+130,527
| +46,286% | +$2.29M |
|
3938
iShares S&P Small-Cap 600 Value ETF
IJS
$8.33B
| $1.8M | ﹤0.01% |
15,801
+14,600
| +1,216% | +$1.64M |
|
3939
Rhinebeck Bancorp
RBKB
$195M
| $1.79M | ﹤0.01% |
148,835
+4,537
| +3% | +$49.8K |
|
3940
Apyx Medical
APYX
$127M
| $1.79M | ﹤0.01% |
510,980
+1,217
| +0.2% | +$4.24K |
|
3941
CALL
iShares MSCI Emerging Markets ETF
EEM
$29.9B
| $1.77M | ﹤0.01% |
32,400
-2,023,300
| -98% | -$110M |
|
3942
iShares AAA-A Rated Corporate Bond ETF
QLTA
$1.21B
| $1.76M | ﹤0.01% |
36,625
-1,507
| -4% | -$73K |
|
3943
Forte Biosciences
FBRX
$1.58B
| $1.76M | ﹤0.01% |
64,496
+13,834
| +27% | +$243K |
|
3944
Torrid Holdings
CURV
$239M
| $1.76M | ﹤0.01% |
1,795,224
+50,789
| +3% | +$64.9K |
|
3945
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.4B
| $1.76M | ﹤0.01% |
37,475
-382
| -1% | -$17.8K |
|
3946
PetMed Express
PETS
$42.3M
| $1.75M | ﹤0.01% |
548,000
+5,265
| +1% | +$13.2K |
|
|
AGEN
3947
Agenus
AGEN
$307M
| $1.75M | ﹤0.01% |
558,345
+11,233
| +2% | +$44.7K |
|
3948
Harbor Long-Term Growers ETF
WINN
$1.19B
| $1.75M | ﹤0.01% |
56,223
| – | – |
|
3949
Alset
AEI
$40.1M
| $1.75M | ﹤0.01% |
508,010
| – | – |
|
3950
Microbot Medical
MBOT
$113M
| $1.74M | ﹤0.01% |
868,652
+378,463
| +77% | +$897K |
|
Similar funds
BlackRock's Q4 2025 Portfolio in Review
As of Q4 2025, BlackRock held 5,676 positions worth $5.92T, up 3.6% from $5.71T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
BlackRock's Q4 2025 filing shows 223 new, 3,159 increased, 1,507 reduced and 143 closed positions. Its largest new stake was Qnity Electronics Inc: 15,929,395 shares worth $1.3B. The largest sale was Kellanova, an estimated $2.54B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2025 buy was Qnity Electronics Inc: 15,929,395 shares worth $1.3B.
- BlackRock added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $6.32B increase.
- BlackRock's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $1.69B.
- BlackRock fully exited Kellanova in Q4 2025, selling an estimated $2.54B.
- BlackRock's ten largest holdings make up 30% of its $5.92T portfolio in Q4 2025.
- BlackRock opened 223 new positions and closed 143 in Q4 2025.
- BlackRock's portfolio value rose 3.6% quarter-over-quarter to $5.92T.
Based on BlackRock's 13F filing for Q4 2025, filed 12 Feb 2026.